Response to the letter by Adams and Kwee, entitled: "Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma"
- PMID: 28707119
- DOI: 10.1007/s00259-017-3773-6
Response to the letter by Adams and Kwee, entitled: "Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma"
Comment on
-
Advanced Hodgkin's lymphoma: End-of-treatment FDG-PET should be maintained.Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1254-1257. doi: 10.1007/s00259-017-3714-4. Eur J Nucl Med Mol Imaging. 2017. PMID: 28466283 No abstract available.
-
Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma.Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1934-1936. doi: 10.1007/s00259-017-3771-8. Eur J Nucl Med Mol Imaging. 2017. PMID: 28707121 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical